Αποτελέσματα Αναζήτησης
3 Φεβ 2016 · Given the challenge facing emergency physicians managing life-threatening acute AE with airway compromise, we investigated the use of FFP to examine its ability to prevent intubation and shorten the course of airway angioedema and hence ICU stays.
Risks with the use of FFP include potential for initial worsening of angioedema (specifically in hereditary angioedema due to its bradykinin content), viral transmission, delayed administration time, allergic/transfusion reactions, and volume overload . Conclusions
Fresh frozen plasma (FFP) is one treatment option for acute bradykinin-induced AE with airway compromise. e rst report of its successful use was in hereditary AE in
10 Σεπ 2015 · Objectives: Fresh frozen plasma (FFP) has been used in angioedema crises, however there is a risk of aggravating the symptoms as well as transmitting infections. In this report, the authors...
FFP has been shown to be of benefit in hereditary angioedema, in which its main action is to replace the deficient C1 esterase inhibitor. In the treatment of ACE-I angioedema, FFP might provide further kininase II, which breaks down accumulated bradykinin, and might also provide functional enzyme in those patients with enzyme defects in ...
Fresh frozen plasma (FFP) is hypothesized to improve AIA by providing additional functional angiotensin converting enzyme to degrade bradykinin. We sought to determine if FFP decreases length of stay, and secondarily the need for airway intervention.
11 Αυγ 2020 · Introduction. Hereditary angioedema due to C1-esterase inhibitor (C1-INH) deficiency is a rare, life-threatening disease that affects about one in 10,000 to one in 150,000 people [1]. Seventy-five percent of cases are autosomal dominant and 25% of cases are due to spontaneous mutation.
